Thrombosis is a very rare complication of Mycoplasma pneumoniae infection. We report the case of a previously healthy nine-year-old boy with cardiac thrombus in the right ventricle associated with M. pneumoniae pneumonia. This cardiac thrombus was detected eight days after the onset of respiratory symptoms. The mechanism underlying thrombosis may be related to autoimmune modulations and was attributable to the production of transient antiphospholipid antibodies.
Introduction
Mycoplasma pneumoniae is a common pathogen of pneumonia in children and adolescents and has been known to cause various kinds of extrapulmonary manifestations including arrthritis, hepatitis, pericarditis, hemolytic anemia, and central nervous system sequelae. Thrombosis associated with M. pneumoniae infection is very rare. Thrombus was frequently detected in the cerebral arteries and a direct invasion mechanism has been proposed w1, 2x. We report a case of cardiac thrombus associated with M. pneumoniae pneumonia wherein transient antiphospholipid antibodies may be related to thrombosis.
Case report
A previously healthy nine-year-old boy complained of persistent fever and dry cough for four days. He was diagnosed with asthma and pneumonia and treated with aminophylline and doxycycline at a local hospital. Four days after the initial treatment, enhanced computed tomography revealed a consolidation in the right lower lobe and a mass in the right ventricle (RV). The patient was referred to us for detailed assessment of the right ventricular mass and treatment of fever. An echocardiogram showed a mass located under the tricuspid valve in the RV and attached to the chorda (Fig. 1a,b) . Several days later, he was almost cured of pneumonia, and the C-reactive protein level was normalized. His family history was nega- tive for vascular diseases or coagulation disorders. A cold agglutinin titer was high at 1:1024. A high-density particle agglutination test revealed a high-level of Mycoplasma antibodies (1:10,240). Coagulation studies showed normal prothrombin time, partial thromboplastin time, fibrinogen, fibrin D-dimer and anti-thrombin III. Laboratory evaluations revealed that the patient tested strongly positive for anticardiolipin IgM (7.2; normal -1.0) but negative for anticardiolipin IgG antibody, lupus anticoagulant (LA), anticardiolipin-b2-glycoprotein I complex, and antinuclear antibody. Protein C and S levels were within the normal range. A lung perfusion scintigram showed no perfusion defect in the lungs. Magnetic resonance imaging performed at 10 days after admission showed that the consolidation in the right lower lobe and the mass in the RV were hypovascular and had similar signal intensity as the surrounding papillary muscles. A second echocardiogram showed that the mass in the RV was partially detached and almost floating in the RV. Hence, this mass along with the involved small tricuspid chorda was immediately removed by cardiac surgery using cardiopulmonary bypass. Pathological examination confirmed that the mass was a comparatively new fibrin thrombus with few leukocytes.
At six months after the operation, the patient tested negative for anticardiolipin IgM antibody. Eight years after the cardiac operation, he is doing well and does not have thrombosis or thromboembolism complication as acertained by telephone interview with his family.
Discussion
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in school-aged children and adolescents. Extrapulmonary manifestations of M. pneumoniae are well-described, including arrthritis, hepatitis, pericarditis, hemolytic anemia, thrombotic thrombocytopenic purpura, encephalitis, transverse myelitis, meningitis and Guillan-Barré syndrome. However, thrombosis associated with M. pneumoniae infection is very rare. To our knowledge, there have been 19 published reports, including 21 cases, since 1980 (Table 1) w1-9x. The age at which thrombosis occurs varies between four and 40 years with median age of eight years of age, and is equivalent to the age at which pneumonia due to M. pneumoniae often occurs. Although the onset of thrombosis varied among the patients, thrombosis developed in patients between a period from eight days to three weeks after the patients developed fever or cough (median duration, 12 days). Thrombus was frequently detected in the cerebral arteries w1-3x. Cardiac thrombosis was extremely rare; only one case of which was reported in the left atrium (LA) and pulmonary veins in a four-year-old boy w6x.
The mechanism underlying thrombosis due to M. pneumoniae remains unknown. A direct invasion mechanism has been proposed in patients with stroke because M. pneumoniae DNA was detected in cerebrospinal fluid w1, 2, 5x. Mycoplasma pneumoniae may cause local vascular injury by inducing cytokine production in the central nerve system w8x. However, simultaneous inflammatory changes in the cerebrospinal fluid, including leukocytosis, were found only in some patients with M. pneumoniae infection w3x.
Another proposed mechanism is autoimmune modulations, which probably explains why there is a period of approximately two weeks between the onset of respiratory symptoms and thrombosis. Recent reports advocated the involvement of antiphospholipid antibodies, such as LA, anticardiolipin antibodies, and anti-b2-glycoprotein I antibodies w4-9x. These autoimmune antibodies are associated with an increased risk of arterial and venous thrombosis, although the mechanism underlying thrombosis remains unclear. Antiphospholipid antibodies are produced in several types of infection. Snowden et al. demonstrated that the number of patients with M. pneumoniae infection and increased anticardiolipin antibody was significantly more than the number of patients with other infections w4x.
Patients with high titers of antiphospholipid antibody tended to have frequent extrapulmonary manifestations or severe symptoms. Thus, far, there are eight cases in which antiphospholipid antibodies were detected in association with thrombosis after M. pneumoniae infection w 4-9x, and eight cases in which no antiphospholipid antibodies were detected despite detailed examination w1-3x. In seven patients of the eight cases in which antiphospholipid antibodies were undetected, thrombosis occurred in the brain, whereas among cases in which antiphospholipid antibodies were detected, the sites of thrombosis differed. Thus, most cases of stroke associated with M. pneumoniae infection may not be related to antiphospholipid antibodies.
Several reports successfully treated thrombus due to M. pneumoniae with anticoagulant therapy including intravenous heparin, intra-subcutaneous injection of low molecular weight heparin and oral administration of warfarin w7-9x. At that time, we did not clearly distinguish the tumor and thrombus. In addition, the large mass was almost floating in the RV. An emergency operation was decided on to remove the mass because of the fear of pulmonary embolism.
During the period from several weeks to -one year after the occurrence of thrombosis in patients with M. pneumoniae infection, almost all antiphospholipid antibodies disappeared or were undetected. Furthermore, new events of thrombosis or thrombogenesis recurrence were not reported during this period w4-9x.
In conclusion, M. pneumoniae infection may cause thrombosis formation and transient production of the antiphospholipid antibodies may involve its mechanism.
